Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally.
$5.24+0.96%
报价 2026-11-06
市值
$344.5M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -5.9%
$2.58$5.57
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Drug Manufacturers - Specialty & Generic| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ACBAurora Cannabis Inc. | $344.5M | +1.0% | – | -5.9% | – | – | – | |
| AQSTAquestive Therapeutics, Inc. | $453.1M | -1.4% | +7.4% | 58.4% | – | – | – | |
| EOLSEvolus, Inc. | $449.5M | +0.1% | +11.5% | 65.6% | – | – | – | |
| KMDAKamada Ltd. | $417.1M | +5.2% | – | 42.3% | 23.3x | 10.8x | – | |
| EMBCEmbecta Corp. | $350.7M | -2.2% | +4.3% | 59.9% | 3.3x | 5.8x | 1.8x | Cheap |
| SNDLSNDL Inc. | $346.4M | +2.5% | – | 19% | – | 8.8x | – | |
| TLRYTilray Brands, Inc. | $326.5M | +3.9% | – | 30.1% | – | – | – | |
| EBSEmergent BioSolutions Inc. | $310.7M | +3.6% | -9.4% | 49.4% | – | – | 4.3x | |
| CGCCanopy Growth Corporation | $275.8M | -3.6% | – | 27.4% | – | – | – | |
| 同行中位数 | – | – | +5.8% | 45.9% | 13.3x | 8.8x | 3.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
报告货币 CAD（非美元）| Metric | 2026-06-30 Q1 2027 | 2026-03-31 Q4 2026 | 2025-12-31 Q3 2026 | 2025-09-30 Q2 2026 | 2025-06-30 Q1 2026 | 2025-03-31 Q4 2025 | 2024-12-31 Q3 2025 | 2024-09-30 Q2 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | CAD 67.6M | CAD 38.1M | CAD 94.2M | CAD 90.4M | CAD 88.2M | CAD 90.5M | CAD 88.2M | CAD 81.1M |
| Gross Margin | -5.9% | 47.8% | 49.5% | 35.7% | 89.6% | 24.2% | 89.6% | 52% |
| Operating Margin | -70.2% | -66.1% | 5.1% | -20.2% | 41.8% | -33.6% | 41.8% | -2.9% |
| Net Income | CAD -4M | CAD -57M | CAD 1.8M | CAD -51.5M | CAD 31.7M | CAD -24.6M | CAD 31.7M | CAD -12M |
| Diluted EPS | -0.07 | -0.99 | 0.03 | -0.91 | 0.57 | -0.44 | 0.58 | -0.22 |
| Operating Cash Flow | CAD -4.4M | CAD -230,000 | CAD 17M | CAD -40.4M | CAD 10.1M | CAD 3.7M | CAD 28.8M | CAD -24.9M |